Skip to content

A Comparison of Bone Formation With Three Different Bone Graft Materials Following Sinus Graft

A Histomorphometric Analysis of Bone Formation With Three Different Bone Graft Materials Following Sinus Augmentation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01911819
Enrollment
22
Registered
2013-07-30
Start date
2013-12-31
Completion date
2016-06-30
Last updated
2017-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inadequate Bone Height in Maxillary Posterior Area

Keywords

Histomorphometric Analysis, New bone Formation, Sinus Augmentation, Bone Graft Materials

Brief summary

The purpose of this study is to compare new bone formation following bone graft in sinus using three different commercially available bone graft materials. The study hypothesis is that there is no difference in new bone formation among three bone graft materials under microscope.

Detailed description

The purpose of this investigation is to compare new bone formation through histomorphometric analysis following maxillary sinus augmentation using three different bone graft materials. Null Hypothesis is that there is no histomorphometric difference in new bone formation in maxillary sinuses augmented using three different materials; anorganic bovine bone graft (Bio-Oss), anorganic equine bone graft (Equimatrix) and mineralized bone allograft (OSSIF-i sem). Patients who require sinus augmentation prior to implant placement will be selected to participate in this study. All patients will be randomly placed into three groups according to bone graft materials that will be used. Group A (Control group,n=10): Maxillary sinus augmentation using anorganic bovine bone graft (Bio-Oss), Group B (Test group,n=10):Maxillary sinus augmentation using anorganic equine bone graft (Equimatrix), and Group C (Test group,n=10):Maxillary sinus augmentation using mineralized bone allograft (OSSIF-i sem). All the patients will be treated with the same surgical technique consisting of sinus floor augmentation via a lateral approach.After a full-thickness flap reflection to expose the lateral wall of the sinus each antrostomy will be outlined with a carbide round bur and sinus membranes will be carefully elevated. If a perforation to the sinus membrane occurs, and if the perforation is \< 5 mm in diameter and is able to be repaired, the surgeon will continue the procedure. Any perforation \> 5 mm will be excluded from this study. Bone graft materials will be placed into the each sinus compartment for the three groups. After 8 months of healing, biopsy specimen will be collected from the previous antrostomy sites. Histomorphometric measurements of the percentage of vital bone of the area of bone. The percentage of non-bone material (allograft or xenograft) and the percentage of connective tissue will be also analyzed. Then the primary hypothesis will be analyzed statistically.

Interventions

PROCEDURESinus augmentation
DRUGEquimatrix

Equimatrix cancellous particle size 0.2-1mm approximately 2g (4cc)

DRUGOSSIF-i sem

OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 2cc x 2

Bio-oss small granules cancellous 0.25-1mm, approximately 2g (4cc)

Sponsors

American Regent, Inc.
CollaboratorINDUSTRY
Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Over 18 years old who are able to read and sign written consent form. 2. Patient who has good oral hygiene (Full-mouth plaque score \<25%). 3. Subject would be available for study monitoring. 4. Patients with missing teeth in the maxillary posterior region who will require sinus augmentation f or implant placement. The patients may be partially or completely edentulous. 5. Delayed implant placement approximately 8 months following sinus grafting.

Exclusion criteria

A medical history that will complicate the outcome of the study such as: 1. alcohol, drug dependency, 2. signs or symptoms of maxillary sinus disease, 3. current smoker, 4. history of head and neck radiation treatment, 5. poor health or any other medical, physical or psychological reason that might affect the surgical procedure or the subsequent prosthodontic treatment and/or required follow-up examinations.

Design outcomes

Primary

MeasureTime frameDescription
The Percentage of Vital Bone in a Total Amount of a Bone Specimen24monthsBone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.

Secondary

MeasureTime frameDescription
The Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.24monthsBone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.

Countries

United States

Participant flow

Pre-assignment details

The enrolled patients had either unilateral or bilateral maxillary sinus requiring maxillary sinus graft. For patients with bilateral sinus, each maxillary sinus was randomly assigned different treatment groups.

Participants by arm

ArmCount
Sinus Augmentation Using Bio-oss
Sinus augmentation using Bio-oss Sinus augmentation Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)
9
Sinus Augmentation Using Bio-oss
Sinus augmentation using Bio-oss Sinus augmentation Bio-oss: Bio-oss small granules cancellous 0.25-1mm, approximately 2.5g (5cc)
9
Sinus Augmentation Using Equimatrix
Sinus augmentation using Equimatrix Sinus augmentation Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)
9
Sinus Augmentation Using Equimatrix
Sinus augmentation using Equimatrix Sinus augmentation Equimatrix: Equimatrix cancellous particle size 0.2-1mm approximately 2.5g (5cc)
9
Sinus Augmentation Using OSSIF-i Sem
Sinus augmentation using OSSIF-i sem Sinus augmentation OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc
10
Sinus Augmentation Using OSSIF-i Sem
Sinus augmentation using OSSIF-i sem Sinus augmentation OSSIF-i sem: OSSIF-i sem Mineralized Cancellous Bone Allograft SP 0.25-1.0mm approximately 5cc
10
Total56

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyAdverse Event010
Overall StudyWithdrawal by Subject110

Baseline characteristics

CharacteristicSinus Augmentation Using Bio-ossSinus Augmentation Using EquimatrixSinus Augmentation Using OSSIF-i SemTotal
Age, Continuous60.9 years65.6 years57.9 years61.5 years
Age, Customized
>=65 years
4 participants5 participants4 participants10 participants
Age, Customized
Between 18 and 65 years
5 participants4 participants6 participants11 participants
Region of Enrollment
United States
9 participants9 participants10 participants21 participants
Sex/Gender, Customized
Female
5 participants3 participants5 participants11 participants
Sex/Gender, Customized
Male
4 participants6 participants5 participants10 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 100 / 10
other
Total, other adverse events
1 / 110 / 100 / 10
serious
Total, serious adverse events
0 / 110 / 100 / 10

Outcome results

Primary

The Percentage of Vital Bone in a Total Amount of a Bone Specimen

Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.

Time frame: 24months

ArmMeasureValue (MEAN)Dispersion
Sinus Augmentation Using Bio-ossThe Percentage of Vital Bone in a Total Amount of a Bone Specimen10.9 percentage of vital boneStandard Deviation 8.9
Sinus Augmentation Using EquimatrixThe Percentage of Vital Bone in a Total Amount of a Bone Specimen9.1 percentage of vital boneStandard Deviation 5.9
Sinus Augmentation Using OSSIF-i SemThe Percentage of Vital Bone in a Total Amount of a Bone Specimen32.0 percentage of vital boneStandard Deviation 12.4
Secondary

The Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.

Bone biopsy was taken in a mean of 9.1 months after sinus graft procedure from previous lateral window of maxillary sinus. The bone cores were analyzed though histomorphometric analysis.

Time frame: 24months

ArmMeasureValue (MEAN)Dispersion
Sinus Augmentation Using Bio-ossThe Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.34.3 percentage of residual bone materialsStandard Deviation 12.1
Sinus Augmentation Using EquimatrixThe Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.38.9 percentage of residual bone materialsStandard Deviation 5.3
Sinus Augmentation Using OSSIF-i SemThe Percentage of Non-vital Bone/Residual Bone Graft Material in a Bone.5.5 percentage of residual bone materialsStandard Deviation 5.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026